Centralised manufacture of Molecularly Targeted Radiation (MTR) Drugs for cancer treatment
Providing better access to life-changing treatments for cancer patients
PLEASE NOTE: IMCRC closed at the end of 2022 and this website is for reference purposes only.
Providing better access to life-changing treatments for cancer patients
Research collaboration to develop and test Industry 4.0 technologies
Modern day applications of advanced carbon materials
Building a pilot plant to produce high-purity alumina (HPA)
Remote controlled load management system to control and manage suspended loads
Advancing biomaterials by providing the best research environment
Enabling the early detection of cardiovascular diseases
Developing “smart’ civil and building infrastructure capability
Next generation product technology that facilitates a flexible and scalable distributed manufacturing model